Position in ABUS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$91,658,798
+$8,149,855 QoQ
Shares Held
19,095,583
+2.9% QoQ
Ownership
9.65%
of shares outstanding
% of Portfolio
3.51%
of 13F equity value
Holder Rank
#1
of 175 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Two Seas Capital LP holds $827,767,805 across 6 Biotechnology names. ABUS ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
8,475,356 | $299,942,848 | |
| 2 | NKTR |
Nektar Therapeutics
|
3,092,234 | $215,868,855 | |
| 3 | IMVT |
Immunovant, Inc.
|
3,148,505 | $121,311,897 | |
| 4 | ABUS |
Arbutus Biopharma Corp
This page
|
19,095,583 | $91,658,798 | |
| 5 | QURE |
uniQure N.V.
|
1,441,410 | $66,391,344 | |
| 6 | ABVX |
Abivax S.A.
|
244,590 | $32,594,063 |
All Filings in ABUS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $91,658,798 | 19,095,583 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $83,508,943 | 18,557,543 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $83,508,943 | 18,557,543 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $60,553,849 | 12,589,158 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $60,553,849 | 12,589,158 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $49,900,324 | 10,991,261 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $32,269,849 | 10,443,317 | Shares | Sole | 2025-08-13 | |
| 2025-06-30 | $32,269,849 | 10,443,317 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $33,036,186 | 9,465,956 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $28,582,926 | 8,740,956 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $32,291,443 | 8,387,388 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $26,486,710 | 8,571,751 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $20,232,171 | 7,841,927 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $22,604,817 | 9,041,927 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,810,060 | 8,280,818 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $19,045,881 | 8,280,818 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $22,618,113 | 7,464,724 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $17,484,769 | 7,504,193 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,798,981 | 5,653,917 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,490,083 | 3,501,876 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,553,225 | 2,199,069 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,211,463 | 825,569 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||